Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Evaluating Cross-Contamination Risk of Highly Potent APIs

Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.
Oct 15, 2014

Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.

Need for Particle Engineering Increases

Micronization and other processes are used to obtain optimal particle characteristics for pulmonary and oral solid-dosage delivery.
Sep 17, 2014

Micronization and other processes are used to obtain optimal particle characteristics for pulmonary and oral solid-dosage delivery.

Modularity Creates Flexible Manufacturing Systems

A roundtable discussion on modular bio/pharmaceutical manufacturing systems to enhance flexibility in facility design.
Sep 2, 2014

Flexibility, which involves the ability to quickly change product capacity or even product type to meet market demand, is increasingly important. In new construction or renovation, modular process skids and modular buildings create this flexibility. Experts discuss trends and challenges.

Preparing to Meet Counterfeiting Regulations

Sep 1, 2014

An expert discusses how companies should be preparing to meet the requirements of the Drug Supply Chain Security Act, which requires phase-in of requirements to prevent counterfeiting.

Lean Manufacturing Improves Process Efficiency

Manufacturers can identify and reduce waste using tools such as value-stream mapping.
Aug 20, 2014

Manufacturers can identify and reduce waste using tools such as value-stream mapping.

Industry Takes Steps to Prevent Counterfeit Drugs

Aug 2, 2014

The fight against counterfeit drugs is an international effort, as exemplified by the ?Fight the Fakes? campaign.

Implementing Supply-Chain Security

Companies in the US drug supply chain should prepare for the coming requirements of the Drug Supply Chain Security Act.
Aug 2, 2014

The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.

Survey Shows Importance of Process Analytical Technology

Pharmaceutical Technology’s survey collected industry feedback on trends and the utility of equipment used in finished drug-product manufacturing.
Jul 16, 2014

Pharmaceutical Technology’s survey collected industry feedback on trends and the utility of equipment used in finished drug-product manufacturing.

Sterilization of Blow-Fill-Seal Equipment for Aseptic Filling

Pharmaceutical Technology spoke with experts from Noxilizer and Weiler Engineering about using nitrogen dioxide to sterilize and depyrogenate the aseptic fill area in a blow-fill-seal process.
Jul 2, 2014

Nitrogen dioxide can sterilize and depyrogenate an aseptic fill area in a blow-fill-seal process.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here